• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceEXCLUDER AAA ENDOPROSTHESIS SIM-PULL
Generic NameSYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
ApplicantW.L. GORE & ASSOCIATES,INC
32360 N. North Valley Parkway
Phoenix, AZ 85085
PMA NumberP020004
Supplement NumberS087
Date Received09/09/2013
Decision Date10/08/2013
Product Code MIH 
Advisory Committee Cardiovascular
Supplement Type30-Day Notice
Supplement Reason Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review Granted? No
Combination ProductNo
RecallsCDRH Recalls
Approval Order Statement  
DUPLICATION OF THE CURRENT COMBINED SIM-PULL AND C3 CATHETER MANUFACTURING PROCESS; ADDITION OF A NEW ISO 8 CLEANROOM AT AN ALREADY APPROVED FACILITY; AND MACHINERY ANDRECIPES UPGRADES AT BOTH APPROVED MANUFACTURING FACILITIES.
Post-Approval StudyShow Report Schedule and Study Progress
-
-